Moderna Inc (MRNA)
125.00
-0.59
(-0.47%)
USD |
NASDAQ |
May 03, 16:00
125.43
+0.43
(+0.34%)
After-Hours: 20:00
Moderna Market Cap: 47.90B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 47.90B |
| May 02, 2024 | 48.13B |
| May 01, 2024 | 42.72B |
| April 30, 2024 | 42.28B |
| April 29, 2024 | 42.78B |
| April 26, 2024 | 41.38B |
| April 25, 2024 | 40.67B |
| April 24, 2024 | 41.69B |
| April 23, 2024 | 41.32B |
| April 22, 2024 | 40.01B |
| April 19, 2024 | 38.84B |
| April 18, 2024 | 39.07B |
| April 17, 2024 | 39.62B |
| April 16, 2024 | 39.75B |
| April 15, 2024 | 39.78B |
| April 12, 2024 | 40.27B |
| April 11, 2024 | 40.98B |
| April 10, 2024 | 41.03B |
| April 09, 2024 | 42.74B |
| April 08, 2024 | 40.25B |
| April 05, 2024 | 39.40B |
| April 04, 2024 | 39.17B |
| April 03, 2024 | 38.76B |
| April 02, 2024 | 39.68B |
| April 01, 2024 | 40.44B |
| Date | Value |
|---|---|
| March 28, 2024 | 40.80B |
| March 27, 2024 | 42.34B |
| March 26, 2024 | 41.13B |
| March 25, 2024 | 42.26B |
| March 22, 2024 | 40.37B |
| March 21, 2024 | 39.85B |
| March 20, 2024 | 39.47B |
| March 19, 2024 | 40.24B |
| March 18, 2024 | 39.92B |
| March 15, 2024 | 39.76B |
| March 14, 2024 | 39.61B |
| March 13, 2024 | 40.78B |
| March 12, 2024 | 42.28B |
| March 11, 2024 | 42.87B |
| March 08, 2024 | 39.45B |
| March 07, 2024 | 38.09B |
| March 06, 2024 | 37.48B |
| March 05, 2024 | 36.51B |
| March 04, 2024 | 36.68B |
| March 01, 2024 | 36.32B |
| February 29, 2024 | 35.24B |
| February 28, 2024 | 37.24B |
| February 27, 2024 | 36.76B |
| February 26, 2024 | 35.92B |
| February 23, 2024 | 36.85B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.048B
Minimum
Aug 05 2019
195.55B
Maximum
Aug 09 2021
49.95B
Average
47.36B
Median
Jun 20 2023
Market Cap Benchmarks
| Merck & Co Inc | 322.99B |
| Pfizer Inc | 157.48B |
| Eli Lilly and Co | 698.52B |
| Johnson & Johnson | 359.25B |
| Novavax Inc | 689.97M |
Market Cap Related Metrics
| PS Ratio | 9.382 |
| Price to Book Value | 3.738 |
| Price | 125.00 |
| Earnings Yield | -12.54% |